Forecasting pharmaceutical expenditure in Europe : adjusting for the impact of rebates and discounts

Espin, J. and Schlander, M. and Godman, B. and Anderson, P. and Mestre-Ferrandiz, J. and Hutchings, A. and Flostrand, S. and Parnaby, A. (2017) Forecasting pharmaceutical expenditure in Europe : adjusting for the impact of rebates and discounts. In: ISPOR 20th Annual European Congress, 2017-11-04 - 2017-11-08. (In Press)

[img]
Preview
Text (Espin-etal-ISPOR-2017-Forecasting-pharmaceutical-expenditure-in-Europe-adjusting-for-the-impact)
Espin_etal_ISPOR_2017_Forecasting_pharmaceutical_expenditure_in_Europe_adjusting_for_the_impact.pdf
Accepted Author Manuscript

Download (130kB)| Preview

    Abstract

    European healthcare systems are under constant pressure to contain healthcare expenditure. Understanding future drug expenditure is an important consideration for payers when formulating policies. QuintileIMS publishes European forecasts that are underpinned by its audited volume data and publicly available list prices. With increasing price pressures, list to net price divergence is growing, although some of this information is commercially sensitive and thus not publicly available. The objective of this study was to further develop an established forecast to account for this divergence and explore its impact.